Cancer Res (2023) 83 (8_Supplement): LB321. Citation Format: Elizabeth Donohue Vo, Yang W. Zhang, Dave Rominger, Jillian M. Silva, Yang J. Zhang, Greg Lee, John ...

Abstract. Previously, we reported on a series of highly potent, selective, and non-covalent CDK7 inhibitors that demonstrated antiproliferative activity against triple-negative breast cancer (TNBC) ...

You do not currently have access to this content.

Cancer Res (2025) 85 (8_Supplement_1): 841. Measurement of plasma and tumor concentrations were completed using standard extraction techniques with quantitation by LC-MS/MS methods. Target modulation ...

Annual Meeting 2026 AACR Journals Simultaneous Publications | American Association for Cancer Research AACR Annual Meeting 2026: AACR Journals’ Simultaneous Publications These AACR journal articles ...

NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio ® (avelumab), a ...

Annual Meeting 2025 AACR Journals Simultaneous Publications | American Association for Cancer Research AACR Annual Meeting 2025: AACR Journals’ Concurrent Publications These journal articles published ...

Cancer Immunol Res (2026) 14 (2_Supplement): A038.

Clin Cancer Res (2009) 15 (13): 4446–4452. Purpose: Multiplexing assay of biomarkers at the point-of-care is an elusive goal for molecular diagnostics. Experimental Design: Here, we report an ...

1Department of Pathology, NYU Grossman School of Medicine, New York, New York.

Abstract. Effects of prolonging adjuvant aromatase inhibitor therapy beyond five years on recurrence and cause-specific mortality: an EBCTCG meta-analysis of individual patient data from 12 randomised ...

1Department of Genetics, Yale University School of Medicine, New Haven, Connecticut.